Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

RPR seeks approval of Campto in 13 European countries

Aug. 9, 1996

Aryl-ureido anticancer agents reported by Universite Laval

Aug. 9, 1996

Ethyol available on Canadian market

July 26, 1996

TPO711: Thrombopoietin useful as bone marrow cell proliferation therapy

July 26, 1996

Anticancer oligonucleotides from Taiho

July 26, 1996

Human Genome Sciences' VIGF antagonists in pipeline

July 26, 1996

New formulation of CGP-41251

July 26, 1996

Tyrosine kinase inhibitors in Pharmacia & Upjohn's pipeline

July 26, 1996

Octapeptide neuromedin B antagonists described

July 26, 1996

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...